Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-28 Sale | 2026-06-01 7:59 pm | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 18,175 | $22.84 | $415,117 | 156,066 (Direct) | View |
| 2021-11-09 Sale | 2021-11-09 5:36 pm | Kadmon Holdings Inc. | KDMN | Carver Kyle SVP, CAO, Controller | 15,420 | $9.5 | $146,490 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-28 Exercise | 2026-06-01 7:59 pm | N/A 2034-12-08 | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 15,000 | $0 | 156,066 (Direct) | View |
| 2026-05-28 Exercise | 2026-06-01 7:59 pm | N/A N/A | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 15,000 | $2.99 | 156,066 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-17 5:23 pm | N/A 2036-04-15 | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 98,946 | $0 | 98,946 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:20 pm | N/A N/A | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 13,290 | $17.84 | 62,510 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:16 pm | N/A N/A | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 28,175 | $0 | 75,800 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 279,408 | $0 | 279,408 (Direct) | View |
Ownership | 2025-11-05 8:01 pm | N/A N/A | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 0 | $0 | 401,560 (Direct) | View |